266. Familial mediterranean fever Clinical trials / Disease details
Clinical trials : 28 / Drugs : 22 - (DrugBank : 5) / Drug target genes : 14 - Drug target pathways : 59
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05418686 (ClinicalTrials.gov) | July 2022 | 10/6/2022 | Study of Colchicine Resistance in Familial Mediterranean Fever | Study Of Colchicine Resistance In Familial Mediterranean Fever | Mediterranean Fever;Colchicine Resistance | Biological: Capillary colchicine dosage in colchicine-resistant Familial Mediterranean Fever patients. | Assistance Publique - Hôpitaux de Paris | NULL | Not yet recruiting | 12 Years | N/A | All | 30 | N/A | France |